FeaturedNeurologyNeuroscience·January 5, 2023·5 min readIntestinal Bacteria May Be an Important Piece in the Jigsaw Puzzle of Multiple SclerosisStudy reveals differences in the composition and functionality of intestinal bacteria of multiple sclerosis patients depending on whether their illness is active or whether they are in treatment.Read More
FeaturedNeurologyNeuroscience·January 5, 2023·3 min readA Tool to Investigate Rare, Previously Inaccessible Cells That Play a Key Role in Multiple SclerosisResearchers have developed a new method to pinpoint a subset of astrocytes that appear to play a role in the development and progression of multiple sclerosis.Read More
FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·December 20, 2022·4 min readMyelin Determines Energy Metabolism in Inhibitory Brain CellsIn PV cells, axons with myelin contain more mitochondria. When myelin is decreased in PV cells, mitochondria also decrease. However, mitochondria increase when myelin is lost in excitatory cells.Read More
FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·December 15, 2022·4 min readPoor Gut Health May Drive Multiple Sclerosis, but a Better Diet May Ease ItResearchers found significantly higher levels of Lcn-2 levels in the stools of patients with multiple sclerosis. This marker correlated with reduced bacterial diversity and increases in other markers of intestinal inflammation. Bacteria that ease inflammatory bowel disease were also reduced in MS patients with high fecal levels of Lcn-2 levels.Read More
FeaturedNeurologyNeuroscience·December 12, 2022·3 min readLight Therapy Found to Relieve Fatigue Syndrome in Multiple SclerosisFatigue is a common symptom associated with multiple sclerosis, affecting up to 99% of patients. Researchers report light box therapy helped measurably improve symptoms of fatigue in those with MS after 14 days.Read More
FeaturedGeneticsNeurologyNeuroscience·December 7, 2022·2 min readNew Genes Linked to Multiple Sclerosis DiscoveredStudy identified three new genes that appear to be involved in the pathologies associated with multiple sclerosis.Read More
FeaturedNeurologyNeuroscience·December 6, 2022·5 min readImmunotherapy Eliminates Disease-Causing Cells in Multiple Sclerosis-Like DiseaseCAR-T, a therapy generally used in the treatment of cancer, has been shown to eliminate unhealthy cells that trigger autoimmunity in mouse models of multiple-sclerosis.Read More
FeaturedNeuroscience·December 2, 2022·3 min readNew Drug a Hopeful Advance for Incurable Neurodegenerative Myelin DiseasesRiluzole, an FDA-approved drug to treat ALS, can, in part, correct the molecular cause of some leukodystrophies.Read More
FeaturedNeurologyNeuroscience·December 1, 2022·4 min readMultiple Sclerosis Therapy Found to Also Improve Gut FloraMultiple sclerosis patients treated with dimethyl fumarate (Tecfidera) showed a reduced proportion of pro-inflammatory types of gut bacteria and an increased growth of "good" bacteria after three months of treatment.Read More
FeaturedNeurologyNeuroscience·November 18, 2022·4 min readA Connection Between Diabetes Medications and Multiple SclerosisPeople over the age of 45 who use anti-hyperglycemic medications to control their Type 2 diabetes are at increased risk of developing multiple sclerosis. However, those who are under 45 and take anti-hyperglycemic medications are at reduced risk of MS.Read More
FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·November 10, 2022·5 min readBlood Stem Cell Transplant Could Reboot Immune System in Multiple Sclerosis Patients80% of patients with multiple sclerosis remain disease-free for the long term following an autologous hematopoietic stem cell transplant.Read More
FeaturedNeurologyNeuroscience·November 7, 2022·5 min readChanging Treatment Can Help Multiple Sclerosis PatientsThe number of relapses in patients with relapsing-remitting multiple sclerosis was better controlled and symptoms of disability were stabilized or improved when patients who discontinued fingolimod changed to either ocrelizumab or natalizumab.Read More
